Page last updated: 2024-08-23

amikacin and Dermatitis Medicamentosa

amikacin has been researched along with Dermatitis Medicamentosa in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N1
Liu, QY; Wang, LF1

Trials

1 trial(s) available for amikacin and Dermatitis Medicamentosa

ArticleYear
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult

2010

Other Studies

1 other study(ies) available for amikacin and Dermatitis Medicamentosa

ArticleYear
[Drug eruption of erythema multiforme caused by amikacin in a case].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2005, Volume: 43, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Child; Drug Eruptions; Erythema Multiforme; Humans; Male

2005